Clinical Trials Browser

Phase 2 × Nasopharyngeal Neoplasms × Paclitaxel × Clear all

NCT00003206 2023-06-15

Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer

Phase 2 Completed

Head and Neck Neoplasms, Nasopharyngeal Neoplasms

NCT02250599 2015-12-30

Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT01797900 2014-09-10

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Phase 2 Completed

Nasopharyngeal Neoplasms

NCT01347424 2013-12-09

Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography

Phase 2 Unknown

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Nasopharyngeal Neoplasms

NCT00025298 2012-09-24

Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx

Phase 2 Terminated

Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

NCT00003327 2008-07-24

Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer

Phase 2 Unknown

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms